Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel C Link

Showing results (111-120 of 165) with videos related to

Pageof 17
Sort By:
Blood|June 8, 2022
IL-1β expression in bone marrow dendritic cells is induced by TLR2 agonists and regulates HSC functionSidan Li, Juo-Chin Yao, Karolyn A Oetjen, et al.
Haematologica|April 15, 2024
Molecular responses in decitabine- and decitabine/ venetoclax-treated patients with acute myeloid leukemia and myelodysplastic syndromesAgata Gruszczynska, Abhishek Maiti, Christopher A Miller, et al.
Blood|September 30, 2010
Complete characterization of the microRNAome in a patient with acute myeloid leukemiaGiridharan Ramsingh, Daniel C Koboldt, Maria Trissal, et al.
Blood Cancer Discovery|January 12, 2022
Genetic and Transcriptional Contributions to Relapse in Normal Karyotype Acute Myeloid LeukemiaAllegra A Petti, Saad M Khan, Ziheng Xu, et al.
Cancer Research|September 10, 2009
Contribution of granulocyte colony-stimulating factor to the acute mobilization of endothelial precursor cells by vascular disrupting agentsYuval Shaked, Terence Tang, Jill Woloszynek, et al.
The Journal of Molecular Diagnostics : JMD|September 28, 2025
Evaluation of Long-Read Genome Sequencing for Genomic Profiling of Myeloid CancersHaley J Abel, Mohamed Mahgoub, Nidhi Davarapalli, et al.
Genome Research|October 12, 2010
Next-generation sequencing identifies the natural killer cell microRNA transcriptomeTodd A Fehniger, Todd Wylie, Elizabeth Germino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 6, 2024
Plasma Proteomic Signature Predicts Myeloid Neoplasm RiskDuc Tran, J Scott Beeler, Jie Liu, et al.
Cancer Research|July 3, 2021
Nonsense-Mediated RNA Decay Is a Unique Vulnerability of Cancer Cells Harboring <i>SF3B1</i> or <i>U2AF1</i> MutationsAbigael Cheruiyot, Shan Li, Sridhar Nonavinkere Srivatsan, et al.
Cancer Cell|March 12, 2014
Functional heterogeneity of genetically defined subclones in acute myeloid leukemiaJeffery M Klco, David H Spencer, Christopher A Miller, et al.
Pageof 17

Showing results (111-120 of 165) with videos related to

Sort By:
Pageof 17
Blood|June 8, 2022
IL-1β expression in bone marrow dendritic cells is induced by TLR2 agonists and regulates HSC functionSidan Li, Juo-Chin Yao, Karolyn A Oetjen, et al.
Haematologica|April 15, 2024
Molecular responses in decitabine- and decitabine/ venetoclax-treated patients with acute myeloid leukemia and myelodysplastic syndromesAgata Gruszczynska, Abhishek Maiti, Christopher A Miller, et al.
Blood|September 30, 2010
Complete characterization of the microRNAome in a patient with acute myeloid leukemiaGiridharan Ramsingh, Daniel C Koboldt, Maria Trissal, et al.
Blood Cancer Discovery|January 12, 2022
Genetic and Transcriptional Contributions to Relapse in Normal Karyotype Acute Myeloid LeukemiaAllegra A Petti, Saad M Khan, Ziheng Xu, et al.
Cancer Research|September 10, 2009
Contribution of granulocyte colony-stimulating factor to the acute mobilization of endothelial precursor cells by vascular disrupting agentsYuval Shaked, Terence Tang, Jill Woloszynek, et al.
The Journal of Molecular Diagnostics : JMD|September 28, 2025
Evaluation of Long-Read Genome Sequencing for Genomic Profiling of Myeloid CancersHaley J Abel, Mohamed Mahgoub, Nidhi Davarapalli, et al.
Genome Research|October 12, 2010
Next-generation sequencing identifies the natural killer cell microRNA transcriptomeTodd A Fehniger, Todd Wylie, Elizabeth Germino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 6, 2024
Plasma Proteomic Signature Predicts Myeloid Neoplasm RiskDuc Tran, J Scott Beeler, Jie Liu, et al.
Cancer Research|July 3, 2021
Nonsense-Mediated RNA Decay Is a Unique Vulnerability of Cancer Cells Harboring <i>SF3B1</i> or <i>U2AF1</i> MutationsAbigael Cheruiyot, Shan Li, Sridhar Nonavinkere Srivatsan, et al.
Cancer Cell|March 12, 2014
Functional heterogeneity of genetically defined subclones in acute myeloid leukemiaJeffery M Klco, David H Spencer, Christopher A Miller, et al.
Pageof 17